34D.F 101.75 (+1.24%)
IT0003492391• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. 34D.F

Diasorin (34D.F) Competitor Comparison

We are evaluating the key criteria listed to compare Diasorin (34D.F) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 55

Dividend yield

0 / 8

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Performance 3 years - 34D.F ranking 0 / 58

These are the competitors of Diasorin in the industry Diagnostics & Research ranked by performance 3 years
1. Meridian Bioscience VIVO
246.63
2. Lantheus Holdings LNTH
239.66
3. Natera NTRA
141.22
4. RadNet RDNT
115.17
5. Medpace Holdings MEDP
95.12
6. Heska HSKA
41.31
7. Waters WAT
23.49
8. PerkinElmer PKI
21.19
9. Ortho Clinical Diagnostics Holdings OCDX
13.74
10. Quest Diagnostics DGX
7.93
11. Agilent Technologies A
3.47
12. Laboratory Corp of America Holdings LH
1.8
13. Thermo Fisher Scientific TMO
-4.52
14. Qiagen QGEN
-5.19
15. Danaher DHR
-7.03
16. Mettler-Toledo MTD
-13.09
17. Sera Prognostics SERA
-18.11
18. Twist Bioscience TWST
-18.45
19. IDEXX Laboratories IDXX
-18.53
20. IQVIA Holdings IQV
-18.84
21. Syneos Health SYNH
-19.01
22. Olink Holding OLK
-22.2
23. DexCom DXCM
-23.08
24. Icon ICLR
-24.72
25. Bioventus BVS
-30.47
26. Anixa Biosciences ANIX
-30.75
27. Exact Sciences EXAS
-32.78
28. MaxCyte MXCT
-35.26
29. Sotera Health SHC
-39.68
30. NeoGenomics NEO
-41.81
31. CareDx CDNA
-47.18
32. Guardant Health GH
-51.73
33. Charles River Laboratories CRL
-53.16
34. National Research NRC
-53.98
35. Myriad Genetics MYGN
-54.67
36. Exagen XGN
-55.67
37. Personalis PSNL
-59.05
38. Illumina ILMN
-65.06
39. Global Cord Blood CO
-67.25
40. Neogen NEOG
-69.79
41. Enzo Biochem ENZ
-70.36
42. Psychemedics PMD
-71.95
43. Biodesix BDSX
-75.84
44. Fulgent Genetics FLGT
-77.98
45. Precipio PRPO
-78.59
46. MDxHealth MDXH
-80.12
47. Pacific Biosciences of California PACB
-86.21
48. Inotiv NOTV
-86.65
49. bioAffinity Technologies BIAF
-88.45
50. Co-Diagnostics CODX
-88.94
51. Trinity Biotech TRIB
-89.06
52. Organovo Holdings ONVO
-89.19
53. Interpace Biosciences IDXG
-89.51
54. Neuronetics STIM
-91.07
55. DarioHealth DRIO
-93.77
56. Prenetics Global PRE
-95.09
57. SeqLL SQL
-95.69
58. Aspira Womens Health AWH
-98.83
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.